6-fluoro-5-[1-[4-[1-[2-(oxan-2-yloxy)ethyl]pyrazol-4-yl]phenyl]piperidin-4-yl]-5H-imidazo[5,1-a]isoindole
C31H34FN5O2 — CID 122650493
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-fluoro-5-[1-[4-[1-[2-(oxan-2-yloxy)ethyl]pyrazol-4-yl]phenyl]piperidin-4-yl]-5H-imidazo[5,1-a]isoindole
6-fluoro-5-[1-[4-[1-[2-(oxan-2-yloxy)ethyl]pyrazol-4-yl]phenyl]piperidin-4-yl]-5H-imidazo[5,1-a]isoindole (PubChem CID 122650493) has the molecular formula C31H34FN5O2 and a molecular weight of 527.64 g/mol. Its IUPAC name is 6-fluoro-5-[1-[4-[1-[2-(oxan-2-yloxy)ethyl]pyrazol-4-yl]phenyl]piperidin-4-yl]-5H-imidazo[5,1-a]isoindole.
Molecular Properties
| Compound Name | 6-fluoro-5-[1-[4-[1-[2-(oxan-2-yloxy)ethyl]pyrazol-4-yl]phenyl]piperidin-4-yl]-5H-imidazo[5,1-a]isoindole |
|---|---|
| PubChem CID | 122650493 |
| Molecular Formula | C31H34FN5O2 |
| Molecular Weight | 527.64 g/mol |
| Exact Mass | 527.27 |
| IUPAC Name | 6-fluoro-5-[1-[4-[1-[2-(oxan-2-yloxy)ethyl]pyrazol-4-yl]phenyl]piperidin-4-yl]-5H-imidazo[5,1-a]isoindole |
| SMILES | Fc1cccc2c1C(C1CCN(c3ccc(-c4cnn(CCOC5CCCCO5)c4)cc3)CC1)n1cncc1-2 |
| InChI | InChI=1S/C31H34FN5O2/c32-27-5-3-4-26-28-19-33-21-37(28)31(30(26)27)23-11-13-35(14-12-23)25-9-7-22(8-10-25)24-18-34-36(20-24)15-17-39-29-6-1-2-16-38-29/h3-5,7-10,18-21,23,29,31H,1-2,6,11-17H2 |
| InChIKey | DGKGUHUGZZSJRL-UHFFFAOYSA-N |
| XLogP | 5.92 |
| TPSA | 57.34 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 527.64 |
| LogP ≤ 5 | 5.92 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122650493 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.